You can:
Name | Alpha-2C adrenergic receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | ADRA2C |
Synonym | alpha2-C4 Adra-2c ADRA2L2 ADRA2RL2 Adrenergic alpha2C- receptor class I [ Show all ] |
Disease | Diabetic nephropathy; Fibromyalgia Hypertension Heart failure Glaucoma Alzheimer disease [ Show all ] |
Length | 462 |
Amino acid sequence | MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ |
UniProt | P18825 |
Protein Data Bank | N/A |
GPCR-HGmod model | P18825 |
3D structure model | This predicted structure model is from GPCR-EXP P18825. |
BioLiP | N/A |
Therapeutic Target Database | T01777 |
ChEMBL | CHEMBL1916 |
IUPHAR | 27 |
DrugBank | BE0004864, BE0000342, BE0004888 |
Name | Yohimbine |
---|---|
Molecular formula | C21H26N2O3 |
IUPAC name | methyl (1S,15R,18S,19R,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate |
Molecular weight | 354.45 |
Hydrogen bond acceptor | 4 |
Hydrogen bond donor | 2 |
XlogP | 2.9 |
Synonyms | Lopac0_001210 37247-87-3 MLS000728591 Amberlite CG-400 NCGC00025018-11 [ Show all ] |
Inchi Key | BLGXFZZNTVWLAY-SCYLSFHTSA-N |
Inchi ID | InChI=1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15-,17-,18-,19+/m0/s1 |
PubChem CID | 8969 |
ChEMBL | CHEMBL15245 |
IUPHAR | 102 |
BindingDB | 50203564, 50013515 |
DrugBank | DB01392 |
Structure | ![]() |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
N/A | N/A | DrugBank | |
IC50 | 27.1 nM | PMID19788200 | BindingDB |
IC50 | 36.0 nM | DrugMatrix in vitro pharmacology data | ChEMBL |
Ki | 0.13 nM | PMID1353247 | BindingDB |
Ki | 0.25 nM | PMID10611634 | BindingDB |
Ki | 0.3 nM | PMID1353247 | BindingDB |
Ki | 0.316228 - 3.16228 nM | PMID7996470, PMID1353247, PMID7908642 | IUPHAR |
Ki | 0.5 nM | PMID25557493, PMID24805037 | ChEMBL |
Ki | 0.5 nM | PMID25557493, PMID24805037 | BindingDB |
Ki | 0.55 nM | PMID9605427 | BindingDB |
Ki | 0.78 nM | PMID7996470 | BindingDB |
Ki | 0.88 nM | PMID15911252 | ChEMBL |
Ki | 1.9 nM | PMID17257841 | BindingDB |
Ki | 2.3 nM | PMID7562902 | BindingDB,ChEMBL |
Ki | 3.02 nM | PMID7996470 | BindingDB |
Ki | 5.162 nM | DrugMatrix in vitro pharmacology data | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417